{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:02:08Z","timestamp":1793289728750,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.dld.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T13:16:44Z","timestamp":1494249404000},"page":"841-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Primary Biliary Cholangitis: advances in management and treatment of the disease"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-1998","authenticated-orcid":false,"given":"Pietro","family":"Invernizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Floreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Craxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Vespasiani Gentilucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Gardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Saverio","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7165-6782","authenticated-orcid":false,"given":"Virginia","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3771-9644","authenticated-orcid":false,"given":"Domenico","family":"Alvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.05.001_bib0005","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"62","author":"Beuers","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0010","unstructured":"http:\/\/www.globalpbc.com\/philosophy."},{"key":"10.1016\/j.dld.2017.05.001_bib0015","unstructured":"Orphanet Quaderno novembre 2016 http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/IT\/Prevalenza_delle_malattie_rare_in_ordine_decrescente_o_casi.pdf."},{"key":"10.1016\/j.dld.2017.05.001_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2013.06.015","article-title":"The limitations and hidden gems of the epidemiology of primary biliary cirrhosis","volume":"46","author":"Podda","year":"2013","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.dld.2017.05.001_bib0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0030","doi-asserted-by":"crossref","first-page":"25906","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.dld.2017.05.001_bib0035","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","author":"European Association for the Study of the Liver","year":"2017","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4254\/wjh.v8.i33.1419","article-title":"Recent advances in the diagnosis and treatment of primary biliary cholangitis","volume":"8","author":"Huang","year":"2016","journal-title":"World Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-1","article-title":"Primary biliary cirrhosis","volume":"3","author":"Kumagi","year":"2008","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.dld.2017.05.001_bib0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.05.001_bib0055","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0060","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.05.001_bib0065","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/liv.12560","article-title":"Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis","volume":"35","author":"Quarneti","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2017.05.001_bib0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.05.001_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2169\/internalmedicine.50.4462","article-title":"Risk factors and prediction of long-term outcome in primary biliary cirrhosis","volume":"50","author":"Ishibashi","year":"2011","journal-title":"Internal Medicine"},{"key":"10.1016\/j.dld.2017.05.001_bib0080","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0085","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes","volume":"26","author":"Jones","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0090","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.dld.2017.05.001_bib0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.28128","article-title":"Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists","volume":"63","author":"Trivedi","year":"2016","journal-title":"Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2017.05.001_bib0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000440754","article-title":"Geoepidemiology, genetic and environmental risk factors for PBC","volume":"33","author":"Zhang","year":"2015","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2017.05.001_bib0105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0125","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response","volume":"60","author":"Trivedi","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.23637","article-title":"American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis","volume":"52","author":"Silveira","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0135","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1665-2681(19)30838-5","article-title":"Predicting outcome in primary biliary cirrhosis","volume":"13","author":"Lammers","year":"2014","journal-title":"Annals of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0140","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.05.001_bib0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cld.2008.02.013","article-title":"Pruritus in primary biliary cirrhosis: pathogenesis and therapy","volume":"12","author":"Bergasa","year":"2008","journal-title":"Clinics in Liver Disease"},{"issue":"2","key":"10.1016\/j.dld.2017.05.001_bib0150","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/MJT.0000000000000387","article-title":"A randomized, placebo-controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis","volume":"24","author":"Silveira","year":"2017","journal-title":"American Journal of Therapeutics"},{"key":"10.1016\/j.dld.2017.05.001_bib0155","doi-asserted-by":"crossref","first-page":"e007985","DOI":"10.1136\/bmjopen-2015-007985","article-title":"RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial","volume":"5","author":"Jopson","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.dld.2017.05.001_bib0160","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/hep.26466","article-title":"Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis","volume":"58","author":"Guanabens","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0165","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2008.02092.x","article-title":"Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study","volume":"103","author":"Solaymani-Dodaran","year":"2008","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.05.001_bib0170","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0185","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/ctg.2015.33","article-title":"Current concepts in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"6","author":"Sclair","year":"2015","journal-title":"Clinical and Translational Gastroenterology"},{"key":"10.1016\/j.dld.2017.05.001_bib0190","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1089\/aid.2016.0051","article-title":"The risk of cardiovascular disease, diabetes, liver-related outcomes, and death over 10 years in HIV\/HCV-coinfected patients with and without steatosis","volume":"32","author":"Down","year":"2016","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.dld.2017.05.001_bib0195","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/ijc.27895","article-title":"2013. Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002","volume":"132","author":"Allemani","year":"2013","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.dld.2017.05.001_bib0200","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC study group","volume":"330","author":"Poupon","year":"1994","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.dld.2017.05.001_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0035-1571273","article-title":"Primary biliary cirrhosis beyond ursodeoxycholic acid","volume":"36","author":"Corpechot","year":"2016","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.dld.2017.05.001_bib0210","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.05.001_bib0215","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.05.001_bib0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-014-8456-5","article-title":"New therapies for primary biliary cirrhosis","volume":"48","author":"Floreani","year":"2015","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10.1016\/j.dld.2017.05.001_bib0225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ajg.2015.20","article-title":"A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia","volume":"110","author":"Hosonuma","year":"2015","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.05.001_bib0230","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.dld.2017.05.001_bib0235","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Molecular Cell"},{"key":"10.1016\/j.dld.2017.05.001_bib0240","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.dld.2017.05.001_bib0245","doi-asserted-by":"crossref","first-page":"G60","DOI":"10.1152\/ajpgi.00170.2004","article-title":"FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade","volume":"288","author":"Li","year":"2005","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.dld.2017.05.001_bib0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.05.001_bib0255","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/jm049904b","article-title":"Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid","volume":"47","author":"Pellicciari","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.dld.2017.05.001_bib0260","unstructured":"EMA\/CHMP\/666310\/2016 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2016\/10\/WC500214166.pdf."},{"key":"10.1016\/j.dld.2017.05.001_bib0265","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817308575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817308575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T17:27:14Z","timestamp":1569259634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817308575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1590865817308575"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.05.001","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Biliary Cholangitis: advances in management and treatment of the disease","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}